Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ACAD —
ACADIA PHARMACEUTICALS INC
CUSIP: 004225108 · Held by 3 superinvestors · Combined value: $82,166,210
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.1% | $40,935,639 | 1,532,596 | ADD | +83,063 |
| 2 | Ken Griffin | 0.0% | $37,539,810 | 1,405,459 | ADD | +909,539 |
| 3 | Ray Dalio | 0.0% | $3,690,761 | 138,179 | REDUCE | -25,066 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +83,063 | +5.7% |
| Ken Griffin | ADD | +909,539 | +183.4% |
| Ray Dalio | REDUCE | -25,066 | -15.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ray Dalio | NEW BUY | +163,245 | New |
| Jim Simons | REDUCE | -98,199 | -6.3% |
| Ken Griffin | REDUCE | -2,634,976 | -84.2% |
Who Owns ACAD? Superinvestor Holdings
ACADIA PHARMACEUTICALS INC is held by 3 tracked superinvestors, with a combined position value of $82 million . The largest positions are held by Jim Simons (0.1% of portfolio), Ken Griffin (0.0% of portfolio), Ray Dalio (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions while 1 reduced or exited.